Abbott Laboratories buy Espresso
Start price
14.08.20
/
50%
€85.17
Target price
04.11.21
€120.00
Performance (%)
31.44%
End price
05.11.21
€111.95
Summary
This prediction ended on 05.11.21 with a price of €111.95. With a performance of 31.44% the BUY prediction by Espresso was a big success. Dividends of €1.82 are taken into consideration when calculating the performance. Espresso has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Abbott Laboratories | 0.728% | 0.728% | -0.648% | -2.228% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to Espresso what are the pros and cons of Abbott Laboratories for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Fair valuation
Good rating
High Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Capable Management
Good culture
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Comments by Espresso for this prediction
In the thread Abbott Laboratories diskutieren
Buy Abbott Laboratories
Kursziel gesetzt auf 120,0
In the thread Trading Abbott Laboratories
Die von Espresso gewählte maximale Laufzeit wurde überschritten